Harmony Biosciences Holdings, Inc. (HRMY) Revenue by Year
Harmony Biosciences Holdings, Inc. generated $868.5M in revenue in fiscal year 2025. This represents an increase of 21.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $959.9M in revenue. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Harmony Biosciences Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
HRMY Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
HRMY Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Harmony Biosciences Holdings, Inc. financials
Frequently Asked Questions
What was Harmony Biosciences Holdings, Inc.'s revenue in fiscal year 2025?
Harmony Biosciences Holdings, Inc. generated $868.5M in revenue in fiscal year 2025.
How fast is Harmony Biosciences Holdings, Inc.'s revenue growing?
Harmony Biosciences Holdings, Inc. (HRMY) revenue rose by 21.5% year over year, from $714.7M to $868.5M in fiscal year 2025.
What is Harmony Biosciences Holdings, Inc.'s revenue over the last twelve months?
Harmony Biosciences Holdings, Inc. (HRMY) reported $959.9M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Harmony Biosciences Holdings, Inc.'s revenue changed over the years?
Across the 7 fiscal years this page covers, Harmony Biosciences Holdings, Inc. (HRMY) revenue went from $6.0M in fiscal year 2019 to $868.5M in fiscal year 2025.
What was Harmony Biosciences Holdings, Inc.'s revenue in the most recent quarter?
Harmony Biosciences Holdings, Inc. (HRMY) reported $261.3M in revenue in Q2 2026. This represents an increase of 30.3% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Harmony Biosciences Holdings, Inc. (HRMY) reported on that line in every period on record.